BOLD

Audentes Therapeutics, Inc
BOLD

Overview Fund Activity
Delisted

BOLD was delisted on the 14th of January, 2020.

Back to rankings

147 hedge funds and large institutions have $1.69B invested in Audentes Therapeutics, Inc in 2019 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 62 increasing their positions, 34 reducing their positions, and 21 closing their positions.

Holders
147
Holders Change
+8
Holders Change %
+5.76%
% of All Funds
3.2%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.17%
New
32
Increased
62
Reduced
34
Closed
21
Calls
$10.3M
Puts
$2.7M
Net Calls
+$7.56M
Net Calls Change
+$4.87M

Top Buyers

1
BG
1
Bellevue Group
Switzerland
$51.9M
2
PHS
2
PFM Health Sciences
California
$122M
3
State Street
3
State Street
Massachusetts
$70.3M
4
BlackRock
4
BlackRock
New York
$126M
5
GPP
5
Great Point Partners
Connecticut
$72.8M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$58.6M
2
Jennison Associates
2
Jennison Associates
New York
$23.3M
3
Wellington Management Group
3
Wellington Management Group
Massachusetts
$111M
4
VVM
4
Versant Venture Management
California
$21M
5
Assenagon Asset Management
5
Assenagon Asset Management
Luxembourg
$0
Name Market Value Shares Shares
Change 		Shares
Change %
BlackRock
1
BlackRock
New York
$126M 3,333,445 +413,768 +14%
PHS
2
PFM Health Sciences
California
$122M 3,228,679 +1,198,198 +59%
RG
3
Redmile Group
California
$113M 2,972,167 +236,900 +9%
Wellington Management Group
4
Wellington Management Group
Massachusetts
$111M 2,934,933 -414,538 -12%
Vanguard Group
5
Vanguard Group
Pennsylvania
$74.6M 1,971,206 +84,659 +4%
GPP
6
Great Point Partners
Connecticut
$72.8M 1,922,937 +350,319 +22%
State Street
7
State Street
Massachusetts
$70.3M 1,855,826 +470,384 +34%
GGHC
8
Gilder Gagnon Howe & Co
New York
$66.6M 1,759,958 +140,127 +9%
O
9
OrbiMed
New York
$64.9M 1,713,069 -101,931 -6%
Fidelity Investments
10
Fidelity Investments
Massachusetts
$58.6M 1,548,363 -1,091,447 -41%
BBA
11
Baker Bros. Advisors
New York
$57M 1,506,438 -208,745 -12%
BG
12
Bellevue Group
Switzerland
$51.9M 1,369,604 +1,369,604 New
CC
13
Casdin Capital
New York
$36.5M 965,000 -45,000 -4%
SI
14
Sofinnova Investments
California
$35.3M 933,640 – –
Victory Capital Management
15
Victory Capital Management
Texas
$34.2M 904,221 +23,620 +3%
Dimensional Fund Advisors
16
Dimensional Fund Advisors
Texas
$26.3M 695,928 +58,392 +9%
Lord, Abbett & Co
17
Lord, Abbett & Co
New Jersey
$26.2M 692,114 +34,983 +5%
Citadel Advisors
18
Citadel Advisors
Florida
$25.4M 671,763 +322,398 +92%
T. Rowe Price Associates
19
T. Rowe Price Associates
Maryland
$23.7M 626,881 -163,987 -21%
Jennison Associates
20
Jennison Associates
New York
$23.3M 615,378 -731,592 -54%
D.E. Shaw & Co
21
D.E. Shaw & Co
New York
$22.4M 592,947 +321,756 +119%
VVM
22
Versant Venture Management
California
$21M 553,916 -249,190 -31%
Millennium Management
23
Millennium Management
New York
$19.6M 518,193 -192,616 -27%
Geode Capital Management
24
Geode Capital Management
Massachusetts
$19.4M 513,384 +74,354 +17%
EAM
25
Eventide Asset Management
Massachusetts
$18.9M 499,000 – –
1
2 3 4 5